Evidence map›Paper›PMID 32914559›Full record

ArticleAging cell2020

Vascular amyloid accumulation alters the gabaergic synapse and induces hyperactivity in a model of cerebral amyloid angiopathy.

Pablo Cisternas, Xavier Taylor, Abigail Perkins, Orlando Maldonado, Elysabeth Allman, Ricardo Cordova, Yamil Marambio, Braulio Munoz, Taylor Pennington, Shunian Xiang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Tau depletion diminishes vascular amyloid-related deficits in a mouse model of cerebral amyloid angiopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Pablo CisternasStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Xavier TaylorStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-1129-4038
Abigail PerkinsStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Orlando MaldonadoStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Elysabeth AllmanStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Ricardo CordovaStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Yamil MarambioStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Braulio MunozStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Taylor PenningtonStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Shunian XiangDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
Jie ZhangDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.
Ruben VidalStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Brady AtwoodStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.
Cristian A Lasagna-ReevesStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0002-5499-3082
Indiana University School of Medicine

Funding

Short-Term Training Program In Biomedical SciencesT35HL110854 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI Brittney-Shea Herbert, Catherine Rufatto Sears · 2012 to 2026
$3.4M
Comprehensive identification and validation of immune and inflammatory signatures associated to Cerebral Amyloid Angiopathy (CAA) utilizing the NanoString technology.R01AG059639 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI LASAGNA-REEVES, CRISTIAN · 2018 to 2022
$3.1M
Studying the Physiological Role of Nuak1 in Tau PathogenesisK22NS092688 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI LASAGNA-REEVES, CRISTIAN · 2015 to 2019
$938k
NIA NIH HHS R01 AG059639NINDS NIH HHS K22 NS092688
6 · The paper itself

Abstract

Cerebral amyloid angiopathy (CAA) is typified by the cerebrovascular deposition of amyloid. The mechanisms underlying the contribution of CAA to neurodegeneration are not currently understood. Although CAA is highly associated with the accumulation of β-amyloid (Aβ), other amyloids are known to associate with the vasculature. Alzheimer's disease (AD) is characterized by parenchymal Aβ deposition and intracellular accumulation of tau as neurofibrillary tangles (NFTs), affecting synapses directly, leading to behavioral and physical impairment. CAA increases with age and is present in 70%-97% of individuals with AD. Studies have overwhelmingly focused on the connection between parenchymal amyloid accumulation and synaptotoxicity; thus, the contribution of vascular amyloid is mostly understudied. Here, synaptic alterations induced by vascular amyloid accumulation and their behavioral consequences were characterized using a mouse model of Familial Danish dementia (FDD), a neurodegenerative disease characterized by the accumulation of Danish amyloid (ADan) in the vasculature. The mouse model (Tg-FDD) displays a hyperactive phenotype that potentially arises from impairment in the GABAergic synapses, as determined by electrophysiological analysis. We demonstrated that the disruption of GABAergic synapse organization causes this impairment and provided evidence that GABAergic synapses are impaired in patients with CAA pathology. Understanding the mechanism that CAA contributes to synaptic dysfunction in AD-related dementias is of critical importance for developing future therapeutic interventions.

Indexed as

Amyloid beta-PeptidesAnimalsCerebral Amyloid AngiopathyDisease Models, AnimalFemaleHumansMaleMiceNeurodegenerative DiseasesAmyloid beta-Peptidescerebral amyloid angiopathyGABAergic synapsessynaptotoxicityvascular amyloid

Identifiers

PMID32914559
PMCPMC7576303
OpenAlexW3086442580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.